ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1959

Stability of DNA Methylation Signature in Primary RA Synovial Fibroblasts Compared with Cultured Fibroblast-like Synoviocytes

Rizi Ai1, Deepa Hammaker2, Wei Wang3 and Gary S. Firestein4, 1University of California San Diego, La Jolla, CA, 2Medicine, UC San Diego, La Jolla, CA, 3Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 4Medicine, University of California San Diego, La Jolla, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Epigenetics, fibroblasts and rheumatoid arthritis, synovium

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Genetics, Genomics and Proteomics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) is an aggressive immune-mediated joint disease with synovial inflammation and joint destruction. Fibroblast-like synoviocytes (FLS) play a key role in mediating inflammation and joint damage. FLS are usually isolated from enzymatically dispersed synovial tissue and expanded in culture for multiple passages to achieve relatively homogenous population. Epigenetic alteration in RA FLS such as DNA methylation has been demonstrated stable for many passages. One critical question is whether the pathogenic genes altered in later passage FLS reflects the epigenome in situ. Therefore, we studied DNA methylation in the primary (P0) passage synovial fibroblasts (SF) and compared the patterns to late passage cells.

Methods:

Genomic DNA from cultured FLS (30 RA, 16 OA) and P0 SF (5 RA, 10 OA) was isolated from synovial tissues obtained at the time of total joint replacement. P0 SF were isolated by enzymatically disaggregating cells and negatively selecting either using anti-CD45 magnetic beads or adherence to plastic. The P0 cells were evaluated by flow cytometry for T cells (RA 1.1±0.2%, OA 0.4±0.1%), B cells (RA 0.2%, OA 0.1%). Methylation levels were measured using Illumina HumanMethylation450 chip. Differentially methylated loci (DMLs) were identified using Welch’s t-test and mapped to gene promoter regions to define differentially methylated genes (DMGs). The overlapped DMGs were calculated using Hypergeometric test. To compare enriched biological pathways, Ingenuity pathway analysis was applied.

Results:

For P0 SF, 18,537 DMLs (difference of β value > 0.1 and q value < 0.05) were identified in 2,756 DMGs. Compared to previously reported 1,714 DMGs in passage 5 (P5), 582 (34.0%) DMGs of P5 were overlapped with DMGs in P0 (p value = 1.32e-149). 75 differentially methylated pathways were significantly enriched between RA and OA in P0, and 15 of them are overlapped with 52 pathways enriched in P5, such as “Complement System” and “NF-κB Signaling” associated with immunity and inflammation.

Because the limited number of P0 RA samples may be underpowered, we decreased DML stringency to q value cutoff of 0.1 to allow more DMGs and enriched pathways included. As a result, 26,267 DMLs (difference of β value > 0.1 and q value < 0.1) located on 3,578 DMGs are identified between RA and OA FLS in P5, in which 798 (46.6%) DMGs of P5 were overlapped with DMGs in P0 (p value = 1.04e-241). In addition, out of 108 significantly enriched pathways between RA and OA in P0, 19 of them are overlapped with pathways enriched in P5. Interestingly, RA-specific pathway “Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis” is overlapped.

Conclusion:

In this study, we have compared the DNA methylation signatures in RA between P0 SF and classically prepared P5 FLS. Even though there were differences in cell populations and processing methods, the overlap was highly significant with nearly half of DMGs between RA and OA in P5 FLS can be found in the P0 SF. Despite potential limitations due to sample size and the fact that P0 SF includes several subsets of fibroblasts, the DNA methylation signature of classical RA FLS in established culture are consistent with the patterns observed in SF.


Disclosure: R. Ai, None; D. Hammaker, None; W. Wang, None; G. S. Firestein, Janssen Pharamceuticals, 2, 5.

To cite this abstract in AMA style:

Ai R, Hammaker D, Wang W, Firestein GS. Stability of DNA Methylation Signature in Primary RA Synovial Fibroblasts Compared with Cultured Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/stability-of-dna-methylation-signature-in-primary-ra-synovial-fibroblasts-compared-with-cultured-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/stability-of-dna-methylation-signature-in-primary-ra-synovial-fibroblasts-compared-with-cultured-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology